| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy in Diabetics | 18 | 2023 | 179 | 2.140 |
Why?
|
| Drug Labeling | 3 | 2017 | 233 | 1.420 |
Why?
|
| Drug Approval | 6 | 2020 | 742 | 1.300 |
Why?
|
| Pregnancy | 108 | 2023 | 29144 | 1.140 |
Why?
|
| Informed Consent | 4 | 2020 | 995 | 1.140 |
Why?
|
| Fetal Diseases | 20 | 2016 | 903 | 1.130 |
Why?
|
| Pregnancy Outcome | 18 | 2022 | 2795 | 1.070 |
Why?
|
| United States Food and Drug Administration | 9 | 2020 | 1584 | 1.060 |
Why?
|
| Pregnancy Complications | 11 | 2022 | 2861 | 1.000 |
Why?
|
| Trisomy | 4 | 2014 | 266 | 0.970 |
Why?
|
| Diabetes, Gestational | 6 | 2023 | 1184 | 0.920 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2022 | 489 | 0.900 |
Why?
|
| Prenatal Diagnosis | 15 | 2014 | 1236 | 0.870 |
Why?
|
| Abortifacient Agents, Steroidal | 2 | 2016 | 19 | 0.830 |
Why?
|
| Labor, Induced | 3 | 2018 | 146 | 0.790 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2015 | 367 | 0.790 |
Why?
|
| Cesarean Section | 11 | 2017 | 1365 | 0.780 |
Why?
|
| Mifepristone | 2 | 2016 | 150 | 0.770 |
Why?
|
| Abortion, Spontaneous | 5 | 2019 | 544 | 0.730 |
Why?
|
| Contraception, Postcoital | 2 | 2011 | 22 | 0.720 |
Why?
|
| Abortion, Threatened | 1 | 2019 | 4 | 0.700 |
Why?
|
| Antihypertensive Agents | 2 | 2022 | 2047 | 0.680 |
Why?
|
| Abortion, Legal | 4 | 2015 | 116 | 0.670 |
Why?
|
| Progestins | 1 | 2020 | 306 | 0.650 |
Why?
|
| Pregnancy Complications, Neoplastic | 3 | 2017 | 255 | 0.640 |
Why?
|
| Choice Behavior | 2 | 2018 | 802 | 0.630 |
Why?
|
| Perinatal Mortality | 2 | 2015 | 105 | 0.600 |
Why?
|
| Cesarean Section, Repeat | 2 | 2009 | 29 | 0.590 |
Why?
|
| Congenital Abnormalities | 9 | 2010 | 707 | 0.580 |
Why?
|
| Delivery, Obstetric | 4 | 2021 | 906 | 0.530 |
Why?
|
| Home Childbirth | 1 | 2015 | 51 | 0.520 |
Why?
|
| Pre-Eclampsia | 5 | 2017 | 1200 | 0.520 |
Why?
|
| Anesthetics, General | 1 | 2017 | 152 | 0.510 |
Why?
|
| Physical Examination | 3 | 2020 | 1237 | 0.510 |
Why?
|
| Chromosome Disorders | 5 | 2013 | 514 | 0.490 |
Why?
|
| Government Regulation | 2 | 2016 | 522 | 0.480 |
Why?
|
| Anesthesia, General | 3 | 2020 | 1171 | 0.470 |
Why?
|
| Ribavirin | 4 | 2022 | 395 | 0.470 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2017 | 2408 | 0.460 |
Why?
|
| Hyperglycemia | 1 | 2022 | 1373 | 0.460 |
Why?
|
| Retinopathy of Prematurity | 2 | 2015 | 421 | 0.450 |
Why?
|
| Lactation | 1 | 2015 | 412 | 0.440 |
Why?
|
| Uterine Rupture | 2 | 2004 | 72 | 0.440 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2004 | 62 | 0.430 |
Why?
|
| Oxygen | 2 | 2015 | 4189 | 0.430 |
Why?
|
| Human Experimentation | 1 | 2013 | 127 | 0.420 |
Why?
|
| Obstetrics | 3 | 2017 | 658 | 0.420 |
Why?
|
| Blood Glucose | 8 | 2022 | 6254 | 0.410 |
Why?
|
| Abnormalities, Drug-Induced | 3 | 2014 | 317 | 0.400 |
Why?
|
| Diethylstilbestrol | 1 | 2011 | 93 | 0.390 |
Why?
|
| Midwifery | 1 | 2012 | 132 | 0.390 |
Why?
|
| Pregnant Women | 1 | 2015 | 568 | 0.370 |
Why?
|
| Nonprescription Drugs | 3 | 2008 | 116 | 0.370 |
Why?
|
| Female | 116 | 2023 | 380193 | 0.370 |
Why?
|
| Vaginal Neoplasms | 1 | 2011 | 106 | 0.370 |
Why?
|
| Fetus | 6 | 2014 | 1880 | 0.360 |
Why?
|
| Fetal Therapies | 1 | 2011 | 100 | 0.360 |
Why?
|
| Infant, Premature, Diseases | 2 | 2015 | 707 | 0.360 |
Why?
|
| Meningomyelocele | 2 | 2011 | 165 | 0.350 |
Why?
|
| Premature Birth | 2 | 2020 | 1721 | 0.350 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2011 | 221 | 0.350 |
Why?
|
| Drug Industry | 1 | 2015 | 746 | 0.340 |
Why?
|
| Anesthesia | 1 | 2020 | 1561 | 0.340 |
Why?
|
| Contraceptives, Postcoital | 2 | 2005 | 16 | 0.330 |
Why?
|
| Education, Medical | 1 | 2020 | 1722 | 0.320 |
Why?
|
| Prescription Drugs | 1 | 2015 | 595 | 0.320 |
Why?
|
| Radiotherapy | 1 | 2015 | 1533 | 0.320 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2008 | 16 | 0.320 |
Why?
|
| Endocrine Disruptors | 1 | 2011 | 237 | 0.310 |
Why?
|
| Politics | 3 | 2011 | 791 | 0.310 |
Why?
|
| Levonorgestrel | 1 | 2008 | 77 | 0.300 |
Why?
|
| Fetal Blood | 11 | 2008 | 1318 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2000 | 3338 | 0.290 |
Why?
|
| Women's Rights | 1 | 2007 | 69 | 0.290 |
Why?
|
| Asphyxia | 1 | 2006 | 57 | 0.280 |
Why?
|
| SAIDS Vaccines | 3 | 1999 | 166 | 0.280 |
Why?
|
| Humans | 122 | 2023 | 744366 | 0.280 |
Why?
|
| Clostridium sordellii | 1 | 2005 | 3 | 0.280 |
Why?
|
| Legislation, Drug | 1 | 2008 | 206 | 0.270 |
Why?
|
| Supreme Court Decisions | 1 | 2007 | 128 | 0.270 |
Why?
|
| Down Syndrome | 1 | 2014 | 880 | 0.270 |
Why?
|
| Obstetric Labor, Premature | 3 | 2003 | 279 | 0.260 |
Why?
|
| Personal Autonomy | 1 | 2008 | 298 | 0.260 |
Why?
|
| Aspirin | 1 | 2017 | 3283 | 0.260 |
Why?
|
| Labor, Obstetric | 3 | 2001 | 333 | 0.260 |
Why?
|
| Pregnancy Trimester, First | 5 | 2023 | 853 | 0.250 |
Why?
|
| Abortion, Therapeutic | 1 | 2004 | 35 | 0.240 |
Why?
|
| Hypoglycemic Agents | 3 | 2008 | 2873 | 0.240 |
Why?
|
| United States | 25 | 2021 | 69872 | 0.240 |
Why?
|
| Clinical Trials as Topic | 3 | 2020 | 7914 | 0.240 |
Why?
|
| Fetal Death | 5 | 2009 | 448 | 0.240 |
Why?
|
| Child Development | 1 | 2015 | 2223 | 0.230 |
Why?
|
| Progesterone Congeners | 1 | 2003 | 42 | 0.230 |
Why?
|
| Abortion, Induced | 3 | 2008 | 458 | 0.230 |
Why?
|
| Hydroxyprogesterones | 1 | 2003 | 25 | 0.230 |
Why?
|
| Oximetry | 1 | 2006 | 471 | 0.220 |
Why?
|
| DNA | 3 | 2013 | 7294 | 0.220 |
Why?
|
| Teratogens | 3 | 2022 | 112 | 0.220 |
Why?
|
| Magnesium Sulfate | 1 | 2003 | 68 | 0.220 |
Why?
|
| Insulin | 7 | 2008 | 6582 | 0.210 |
Why?
|
| Amniotic Fluid | 6 | 2000 | 370 | 0.210 |
Why?
|
| Genetic Testing | 2 | 2014 | 3444 | 0.210 |
Why?
|
| Breech Presentation | 1 | 2002 | 44 | 0.210 |
Why?
|
| Heart | 1 | 2015 | 4464 | 0.210 |
Why?
|
| Private Sector | 1 | 2005 | 392 | 0.210 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2009 | 214 | 0.200 |
Why?
|
| Infant, Newborn | 29 | 2017 | 25628 | 0.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3595 | 0.200 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2023 | 732 | 0.200 |
Why?
|
| Microcephaly | 2 | 2016 | 432 | 0.190 |
Why?
|
| Metformin | 1 | 2008 | 836 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2008 | 861 | 0.190 |
Why?
|
| Gynecological Examination | 1 | 2020 | 33 | 0.190 |
Why?
|
| Glyburide | 1 | 2000 | 113 | 0.180 |
Why?
|
| Pregnancy Complications, Infectious | 5 | 2021 | 2026 | 0.180 |
Why?
|
| Biological Specimen Banks | 1 | 2005 | 711 | 0.180 |
Why?
|
| Parathyroid Neoplasms | 2 | 2011 | 245 | 0.180 |
Why?
|
| Fetal Organ Maturity | 5 | 2009 | 82 | 0.180 |
Why?
|
| Pulmonary Surfactants | 2 | 2000 | 162 | 0.170 |
Why?
|
| alpha-Fetoproteins | 2 | 1991 | 224 | 0.170 |
Why?
|
| Health Policy | 1 | 2011 | 2661 | 0.170 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2002 | 407 | 0.170 |
Why?
|
| Clostridium Infections | 1 | 2005 | 548 | 0.170 |
Why?
|
| Neural Crest | 1 | 2001 | 275 | 0.160 |
Why?
|
| Phosphatidylcholines | 2 | 2000 | 411 | 0.160 |
Why?
|
| Gestational Age | 17 | 2009 | 3493 | 0.160 |
Why?
|
| Women's Health | 1 | 2008 | 2034 | 0.160 |
Why?
|
| Cognition | 1 | 2015 | 6770 | 0.160 |
Why?
|
| Infant, Premature | 4 | 2002 | 2045 | 0.150 |
Why?
|
| Hospitalization | 2 | 2021 | 10259 | 0.150 |
Why?
|
| History, 20th Century | 3 | 2012 | 2740 | 0.150 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2017 | 68 | 0.150 |
Why?
|
| Anencephaly | 2 | 2007 | 20 | 0.140 |
Why?
|
| Gynecology | 1 | 2002 | 513 | 0.140 |
Why?
|
| Intelligence | 1 | 2002 | 920 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2002 | 1147 | 0.140 |
Why?
|
| Simian immunodeficiency virus | 4 | 1999 | 846 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 9955 | 0.140 |
Why?
|
| Decidua | 1 | 1996 | 86 | 0.140 |
Why?
|
| Voluntary Health Agencies | 1 | 2015 | 39 | 0.130 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2017 | 109 | 0.130 |
Why?
|
| Drug Information Services | 1 | 2015 | 51 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1996 | 233 | 0.130 |
Why?
|
| Fetal Macrosomia | 3 | 2005 | 124 | 0.130 |
Why?
|
| Embryo Research | 1 | 2015 | 60 | 0.130 |
Why?
|
| Mass Screening | 2 | 2023 | 5253 | 0.130 |
Why?
|
| Placenta, Retained | 1 | 2014 | 21 | 0.120 |
Why?
|
| Uterine Inertia | 1 | 2014 | 29 | 0.120 |
Why?
|
| Progesterone | 1 | 2019 | 775 | 0.120 |
Why?
|
| Brain | 3 | 2017 | 26388 | 0.120 |
Why?
|
| Pancreatitis | 2 | 2011 | 1092 | 0.120 |
Why?
|
| Risk | 5 | 2013 | 9688 | 0.120 |
Why?
|
| Pregnancy, Multiple | 3 | 1994 | 217 | 0.120 |
Why?
|
| Ultrasonography | 12 | 1989 | 5984 | 0.120 |
Why?
|
| Therapeutic Equipoise | 1 | 2013 | 28 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 245 | 0.110 |
Why?
|
| Physician-Patient Relations | 3 | 2020 | 3229 | 0.110 |
Why?
|
| State Government | 1 | 2016 | 372 | 0.110 |
Why?
|
| Placenta | 1 | 2022 | 1699 | 0.110 |
Why?
|
| Anticonvulsants | 1 | 2003 | 1916 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2001 | 1695 | 0.110 |
Why?
|
| Vaccines, Attenuated | 4 | 1999 | 342 | 0.110 |
Why?
|
| Physicians | 2 | 2008 | 4567 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13693 | 0.100 |
Why?
|
| Vaccines | 1 | 2021 | 823 | 0.100 |
Why?
|
| Uterus | 1 | 1996 | 711 | 0.100 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 5 | 1999 | 570 | 0.100 |
Why?
|
| Hypercalcemia | 2 | 2011 | 409 | 0.100 |
Why?
|
| Risk Factors | 11 | 2020 | 72296 | 0.100 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 1320 | 0.100 |
Why?
|
| AIDS Vaccines | 2 | 1995 | 938 | 0.100 |
Why?
|
| Hysterectomy | 1 | 2017 | 927 | 0.100 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2015 | 430 | 0.100 |
Why?
|
| Placenta Previa | 1 | 2012 | 117 | 0.100 |
Why?
|
| Postpartum Hemorrhage | 1 | 2014 | 258 | 0.090 |
Why?
|
| Menotropins | 1 | 1990 | 45 | 0.090 |
Why?
|
| Adenoma | 2 | 2011 | 2174 | 0.090 |
Why?
|
| Mullerian Ducts | 1 | 2011 | 198 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 693 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2012 | 720 | 0.090 |
Why?
|
| Fetal Monitoring | 2 | 2006 | 70 | 0.090 |
Why?
|
| Hyperparathyroidism | 1 | 2011 | 339 | 0.090 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 426 | 0.090 |
Why?
|
| Time | 1 | 2011 | 542 | 0.090 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2011 | 160 | 0.090 |
Why?
|
| Vasculitis | 1 | 2013 | 519 | 0.080 |
Why?
|
| Infant Mortality | 3 | 2004 | 754 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1796 | 0.080 |
Why?
|
| Lung | 4 | 2009 | 9857 | 0.080 |
Why?
|
| Critical Care | 1 | 2021 | 2647 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 5135 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1677 | 0.080 |
Why?
|
| Civil Rights | 1 | 2008 | 132 | 0.080 |
Why?
|
| Chromosomes, Human, 13-15 | 2 | 1986 | 52 | 0.080 |
Why?
|
| Hemorrhage | 2 | 2019 | 3461 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 3922 | 0.070 |
Why?
|
| Blood Banks | 1 | 2008 | 111 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2002 | 9145 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2002 | 4369 | 0.070 |
Why?
|
| Breast Feeding | 1 | 2015 | 1338 | 0.070 |
Why?
|
| Ovulation | 1 | 2008 | 189 | 0.070 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 1996 | 1540 | 0.070 |
Why?
|
| Heart Rate, Fetal | 1 | 2006 | 75 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2012 | 1534 | 0.070 |
Why?
|
| Paternal Exposure | 1 | 2007 | 89 | 0.070 |
Why?
|
| Hernia, Umbilical | 1 | 2007 | 96 | 0.070 |
Why?
|
| Hydranencephaly | 1 | 1985 | 5 | 0.070 |
Why?
|
| Adult | 31 | 2021 | 214052 | 0.070 |
Why?
|
| Globins | 4 | 1988 | 416 | 0.070 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2006 | 88 | 0.070 |
Why?
|
| Vagina | 1 | 2011 | 825 | 0.070 |
Why?
|
| Blood Donors | 1 | 2008 | 355 | 0.070 |
Why?
|
| Fetal Development | 1 | 2011 | 767 | 0.060 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2008 | 314 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2017 | 2987 | 0.060 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2006 | 162 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2017 | 2020 | 0.060 |
Why?
|
| Cushing Syndrome | 1 | 2006 | 249 | 0.060 |
Why?
|
| Morals | 1 | 2008 | 285 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 1997 | 500 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 3070 | 0.060 |
Why?
|
| Trial of Labor | 1 | 2004 | 80 | 0.060 |
Why?
|
| Macaca | 2 | 1996 | 440 | 0.060 |
Why?
|
| Autoimmune Diseases | 2 | 2013 | 2134 | 0.060 |
Why?
|
| Calcium | 1 | 1997 | 5755 | 0.060 |
Why?
|
| Chromosome Aberrations | 3 | 1988 | 1813 | 0.060 |
Why?
|
| Oligohydramnios | 2 | 2001 | 35 | 0.060 |
Why?
|
| Rh Isoimmunization | 2 | 2017 | 21 | 0.060 |
Why?
|
| Patient Selection | 1 | 2015 | 4216 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2008 | 670 | 0.060 |
Why?
|
| Immunosuppressive Agents | 2 | 2013 | 4153 | 0.060 |
Why?
|
| History, 17th Century | 1 | 2003 | 111 | 0.050 |
Why?
|
| Craniosynostoses | 1 | 2007 | 401 | 0.050 |
Why?
|
| Maternal Mortality | 1 | 2005 | 310 | 0.050 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1983 | 102 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2007 | 895 | 0.050 |
Why?
|
| Eclampsia | 1 | 2003 | 58 | 0.050 |
Why?
|
| Nifedipine | 1 | 2003 | 227 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7730 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 2064 | 0.050 |
Why?
|
| History, 18th Century | 1 | 2003 | 213 | 0.050 |
Why?
|
| Neoplasms, Fibroepithelial | 1 | 2001 | 8 | 0.050 |
Why?
|
| Cerebral Palsy | 1 | 2006 | 459 | 0.050 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1983 | 183 | 0.050 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1982 | 189 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 1996 | 2726 | 0.050 |
Why?
|
| Registries | 2 | 2022 | 8091 | 0.050 |
Why?
|
| Thrombophlebitis | 2 | 1996 | 309 | 0.050 |
Why?
|
| Infant | 3 | 2022 | 35134 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2001 | 405 | 0.050 |
Why?
|
| Hydrocephalus | 2 | 1986 | 748 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 2124 | 0.040 |
Why?
|
| Safety | 2 | 2014 | 1186 | 0.040 |
Why?
|
| Blood Transfusion, Intrauterine | 3 | 1988 | 26 | 0.040 |
Why?
|
| Sepsis | 2 | 2009 | 2593 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4933 | 0.040 |
Why?
|
| Albumins | 3 | 2000 | 568 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2001 | 488 | 0.040 |
Why?
|
| Sulfonylurea Compounds | 1 | 2000 | 205 | 0.040 |
Why?
|
| Erythroblastosis, Fetal | 3 | 1988 | 60 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2003 | 976 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 1637 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 623 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2008 | 2055 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 14723 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 1992 | 1101 | 0.040 |
Why?
|
| Urinary Bladder | 3 | 1993 | 1173 | 0.040 |
Why?
|
| Gene Deletion | 2 | 1996 | 2751 | 0.040 |
Why?
|
| Adolescent | 7 | 2017 | 85779 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 1991 | 3112 | 0.040 |
Why?
|
| Salpingectomy | 1 | 2017 | 53 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2017 | 41005 | 0.040 |
Why?
|
| Research | 1 | 2005 | 1999 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2327 | 0.040 |
Why?
|
| Genes, vpr | 1 | 1996 | 20 | 0.040 |
Why?
|
| Endometritis | 1 | 1996 | 48 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 1997 | 1151 | 0.030 |
Why?
|
| Genes, nef | 1 | 1996 | 55 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 1620 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2002 | 986 | 0.030 |
Why?
|
| Hypertension | 3 | 2006 | 8479 | 0.030 |
Why?
|
| Trust | 1 | 2020 | 505 | 0.030 |
Why?
|
| Blood Specimen Collection | 2 | 1988 | 246 | 0.030 |
Why?
|
| Retroviruses, Simian | 1 | 1995 | 12 | 0.030 |
Why?
|
| Chorionic Villi | 1 | 1995 | 51 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 867 | 0.030 |
Why?
|
| Abortion, Habitual | 1 | 1995 | 70 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 1999 | 600 | 0.030 |
Why?
|
| Forecasting | 2 | 2002 | 2951 | 0.030 |
Why?
|
| Incidence | 4 | 2001 | 20952 | 0.030 |
Why?
|
| HIV Infections | 2 | 1999 | 16715 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2017 | 661 | 0.030 |
Why?
|
| Reproductive Techniques | 1 | 1994 | 42 | 0.030 |
Why?
|
| Male | 18 | 2022 | 350115 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2011 | 571 | 0.030 |
Why?
|
| Triplets | 2 | 1994 | 43 | 0.030 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 469 | 0.030 |
Why?
|
| Educational Status | 1 | 2002 | 2540 | 0.030 |
Why?
|
| Child of Impaired Parents | 1 | 2017 | 455 | 0.030 |
Why?
|
| Heart Defects, Congenital | 2 | 2007 | 4583 | 0.030 |
Why?
|
| Placenta Diseases | 1 | 1995 | 199 | 0.030 |
Why?
|
| Genes | 2 | 1987 | 1893 | 0.030 |
Why?
|
| Ectromelia | 1 | 1993 | 31 | 0.030 |
Why?
|
| Hematoxylin | 1 | 1992 | 64 | 0.030 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 1992 | 72 | 0.030 |
Why?
|
| Urethral Obstruction | 2 | 1993 | 56 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 63107 | 0.030 |
Why?
|
| Low Back Pain | 2 | 2011 | 956 | 0.030 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1992 | 81 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 1996 | 371 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1996 | 1423 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1994 | 362 | 0.030 |
Why?
|
| Animals | 11 | 2022 | 168768 | 0.030 |
Why?
|
| Edema | 2 | 1986 | 789 | 0.030 |
Why?
|
| Anthropometry | 2 | 1995 | 1350 | 0.030 |
Why?
|
| Microcirculation | 1 | 1996 | 1287 | 0.030 |
Why?
|
| Sweden | 1 | 2014 | 1341 | 0.020 |
Why?
|
| Virulence | 1 | 1995 | 1333 | 0.020 |
Why?
|
| Arteries | 1 | 1996 | 1119 | 0.020 |
Why?
|
| Kidney Diseases, Cystic | 1 | 1992 | 186 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 456 | 0.020 |
Why?
|
| Reference Standards | 1 | 1995 | 1025 | 0.020 |
Why?
|
| Quadruplets | 1 | 1990 | 9 | 0.020 |
Why?
|
| Abnormalities, Multiple | 2 | 2001 | 1416 | 0.020 |
Why?
|
| Clomiphene | 1 | 1990 | 72 | 0.020 |
Why?
|
| Virus Replication | 2 | 1995 | 2535 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1999 | 1178 | 0.020 |
Why?
|
| Abdominal Muscles | 1 | 1991 | 166 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 1994 | 577 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 8300 | 0.020 |
Why?
|
| Polyhydramnios | 1 | 1989 | 41 | 0.020 |
Why?
|
| Coloring Agents | 1 | 1972 | 566 | 0.020 |
Why?
|
| South Dakota | 1 | 2008 | 30 | 0.020 |
Why?
|
| Head | 1 | 1995 | 880 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2013 | 77460 | 0.020 |
Why?
|
| Autopsy | 1 | 1992 | 1020 | 0.020 |
Why?
|
| Reference Values | 1 | 1996 | 4982 | 0.020 |
Why?
|
| Models, Biological | 2 | 1996 | 9584 | 0.020 |
Why?
|
| Amniocentesis | 1 | 1988 | 116 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 2249 | 0.020 |
Why?
|
| Reproductive Rights | 1 | 2008 | 35 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15297 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 1999 | 2278 | 0.020 |
Why?
|
| Age Factors | 1 | 2005 | 18373 | 0.020 |
Why?
|
| Puerperal Disorders | 1 | 1991 | 275 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 1991 | 244 | 0.020 |
Why?
|
| Noonan Syndrome | 1 | 1989 | 122 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1989 | 140 | 0.020 |
Why?
|
| Vomiting | 1 | 2011 | 637 | 0.020 |
Why?
|
| Infertility, Female | 1 | 1994 | 788 | 0.020 |
Why?
|
| Fetal Hemoglobin | 2 | 1988 | 341 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2013 | 738 | 0.020 |
Why?
|
| Gene Products, vpr | 2 | 1999 | 36 | 0.020 |
Why?
|
| Fetal Distress | 1 | 1987 | 40 | 0.020 |
Why?
|
| Gene Products, nef | 2 | 1999 | 110 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2021 | 5316 | 0.020 |
Why?
|
| Butyrates | 1 | 1987 | 163 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
| Birth Weight | 1 | 1995 | 2069 | 0.020 |
Why?
|
| Gigantism | 1 | 1986 | 15 | 0.020 |
Why?
|
| Observer Variation | 1 | 1992 | 2593 | 0.020 |
Why?
|
| Maternal Age | 1 | 1989 | 802 | 0.020 |
Why?
|
| Rats | 2 | 2001 | 24252 | 0.020 |
Why?
|
| Charities | 1 | 2005 | 31 | 0.020 |
Why?
|
| Polycythemia | 1 | 1986 | 126 | 0.020 |
Why?
|
| Twins, Conjoined | 1 | 1985 | 41 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 12961 | 0.020 |
Why?
|
| Macaca mulatta | 3 | 1999 | 2377 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8642 | 0.020 |
Why?
|
| Maternal Welfare | 1 | 2005 | 115 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1986 | 250 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2011 | 1064 | 0.020 |
Why?
|
| Europe | 1 | 1991 | 3338 | 0.020 |
Why?
|
| Young Adult | 3 | 2017 | 56429 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 1991 | 1782 | 0.020 |
Why?
|
| Linear Models | 1 | 2014 | 5953 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1986 | 256 | 0.010 |
Why?
|
| Speech | 1 | 2008 | 541 | 0.010 |
Why?
|
| Needles | 1 | 1986 | 449 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1992 | 2969 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1986 | 544 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15535 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12788 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11031 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 1990 | 1284 | 0.010 |
Why?
|
| Karyotyping | 3 | 1989 | 1243 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1982 | 212 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 1986 | 608 | 0.010 |
Why?
|
| Amnion | 1 | 1982 | 209 | 0.010 |
Why?
|
| Time Factors | 3 | 1992 | 40075 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2007 | 23336 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 1994 | 15078 | 0.010 |
Why?
|
| Polyps | 1 | 2001 | 189 | 0.010 |
Why?
|
| Aging | 1 | 1999 | 8664 | 0.010 |
Why?
|
| Prognosis | 3 | 2017 | 29060 | 0.010 |
Why?
|
| Prospective Studies | 3 | 1995 | 53290 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13409 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 1991 | 1912 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2006 | 1826 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 1999 | 18111 | 0.010 |
Why?
|
| Heparin | 1 | 1985 | 1637 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1985 | 1151 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1987 | 2455 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 1993 | 18034 | 0.010 |
Why?
|
| Emergencies | 1 | 2004 | 1170 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15221 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6621 | 0.010 |
Why?
|
| Kidney | 1 | 1993 | 7184 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7282 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 1986 | 1848 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6489 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2001 | 1851 | 0.010 |
Why?
|
| Child | 2 | 2017 | 77709 | 0.010 |
Why?
|
| Diabetes Mellitus | 3 | 1989 | 5749 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2008 | 3743 | 0.010 |
Why?
|
| HIV-1 | 1 | 1993 | 6939 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 490 | 0.010 |
Why?
|
| Methylation | 2 | 1988 | 1106 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1525 | 0.010 |
Why?
|
| Surface-Active Agents | 1 | 1994 | 159 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1995 | 294 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1986 | 3390 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1999 | 792 | 0.010 |
Why?
|
| Professional-Patient Relations | 1 | 1999 | 737 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1987 | 7721 | 0.010 |
Why?
|
| Retroviridae Infections | 1 | 1993 | 151 | 0.010 |
Why?
|
| Disclosure | 1 | 1999 | 736 | 0.010 |
Why?
|
| Fibrin | 1 | 1995 | 506 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1985 | 2375 | 0.010 |
Why?
|
| Twins | 1 | 1994 | 339 | 0.010 |
Why?
|
| Echocardiography | 1 | 1985 | 5099 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 12797 | 0.010 |
Why?
|
| Microtomy | 1 | 1972 | 47 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 1993 | 337 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1129 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 40559 | 0.010 |
Why?
|
| Suction | 1 | 1992 | 267 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1995 | 673 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 794 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 4253 | 0.010 |
Why?
|
| Urinary Diversion | 1 | 1991 | 138 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 6459 | 0.010 |
Why?
|
| Succinylcholine | 1 | 1989 | 67 | 0.010 |
Why?
|
| Lymphangioma | 1 | 1989 | 65 | 0.010 |
Why?
|
| Anesthesia, Intravenous | 1 | 1989 | 130 | 0.000 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1988 | 108 | 0.000 |
Why?
|
| Hydrops Fetalis | 1 | 1988 | 107 | 0.000 |
Why?
|
| Chorioamnionitis | 1 | 1989 | 155 | 0.000 |
Why?
|
| Anesthesia, Inhalation | 1 | 1989 | 222 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1995 | 3914 | 0.000 |
Why?
|
| Hematocrit | 1 | 1988 | 636 | 0.000 |
Why?
|
| ROC Curve | 1 | 1994 | 3528 | 0.000 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1986 | 56 | 0.000 |
Why?
|
| Macrophages | 2 | 1995 | 5660 | 0.000 |
Why?
|
| Colony-Forming Units Assay | 1 | 1986 | 356 | 0.000 |
Why?
|
| Punctures | 1 | 1988 | 374 | 0.000 |
Why?
|
| Middle Aged | 2 | 2017 | 213390 | 0.000 |
Why?
|
| Kell Blood-Group System | 1 | 1985 | 22 | 0.000 |
Why?
|
| Monocytes | 1 | 1995 | 2596 | 0.000 |
Why?
|
| Embryonic and Fetal Development | 1 | 1987 | 438 | 0.000 |
Why?
|
| Fentanyl | 1 | 1989 | 409 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 419 | 0.000 |
Why?
|
| Isoflurane | 1 | 1989 | 380 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1993 | 1821 | 0.000 |
Why?
|
| Hemoglobin A | 1 | 1985 | 87 | 0.000 |
Why?
|
| C-Peptide | 1 | 1986 | 419 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1995 | 4026 | 0.000 |
Why?
|
| Pedigree | 1 | 1993 | 4642 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1986 | 449 | 0.000 |
Why?
|
| Sheep | 1 | 1987 | 1437 | 0.000 |
Why?
|
| Disease Progression | 1 | 1999 | 13286 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1995 | 11366 | 0.000 |
Why?
|
| Spinal Neoplasms | 1 | 1989 | 760 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1993 | 3177 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1987 | 1532 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1988 | 2634 | 0.000 |
Why?
|
| Fetal Growth Retardation | 1 | 1985 | 570 | 0.000 |
Why?
|
| Cells, Cultured | 2 | 1987 | 19233 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1994 | 12244 | 0.000 |
Why?
|
| Erythropoietin | 1 | 1985 | 726 | 0.000 |
Why?
|
| Abdomen | 1 | 1986 | 1118 | 0.000 |
Why?
|
| Kinetics | 1 | 1987 | 6476 | 0.000 |
Why?
|
| Femur | 1 | 1986 | 1297 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 35425 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1986 | 1359 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 1993 | 39052 | 0.000 |
Why?
|
| Cell Division | 1 | 1986 | 4569 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1994 | 8551 | 0.000 |
Why?
|
| Gene Expression Regulation | 2 | 1988 | 12073 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1995 | 10183 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1994 | 21748 | 0.000 |
Why?
|
| Mutation | 1 | 1999 | 29786 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1986 | 20130 | 0.000 |
Why?
|